摘要
(R)-蓖麻酸(RA) [(12R,9Z)-羟基十八酸 ],蓖麻籽油的主要化合物,因其独特的结构,很容易进行多方位的化学和生物化学转换产生和保留碳骨架或其降解衍生物。其中许多都是高生物活性,如记录的一个在体外研究中,呈现出治疗潜力。这篇综述提供了该地区的合成与抗癌和抗菌活性的类风湿性关节炎的化合物的最新进展的概述。此外,一些蓖麻酸衍生物的抗炎和镇痛特性也是重点。
关键词: 蓖麻油酸,蓖麻油衍生物,生物活性,抗菌活性抗肿瘤活性,蓖麻,聚酯,生物聚合物。
Current Medicinal Chemistry
Title:Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review
Volume: 23 Issue: 35
Author(s): Sylwia Pabiś and Józef Kula
Affiliation:
关键词: 蓖麻油酸,蓖麻油衍生物,生物活性,抗菌活性抗肿瘤活性,蓖麻,聚酯,生物聚合物。
摘要: (R)-Ricinoleic acid (RA) [(12R,9Z)-hydroxyoctadecenoic acid], the main compound of castor seed oil, because of its unusual structure readily undergoes multi-directional chemical and biochemical transformations to produce derivatives with the retained carbon skeleton or with its degradation. Many of these are of high biological activity, as documented by an in vitro study, and possess therapeutic potential. This review article provides an overview of the recent developments in the area of synthesis of RA based compounds with anticancer and antimicrobial activities. Moreover, the antiinflammatory and analgesic properties of some ricinoleic acid derivatives are also highlighted.
Export Options
About this article
Cite this article as:
Sylwia Pabiś and Józef Kula , Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review, Current Medicinal Chemistry 2016; 23 (35) . https://dx.doi.org/10.2174/0929867323666160627104453
DOI https://dx.doi.org/10.2174/0929867323666160627104453 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult
Current Neuropharmacology Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Current Medicinal Chemistry Nerve Injury Associated with Regional Anesthesia
Current Topics in Medicinal Chemistry Is the Therapeutic Potential of Stem Cells for Myocardial Regeneration Limited by Proarrhythmic Effects?
Current Cardiology Reviews Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology The Pelvic Floor During Pregnancy and after Childbirth, and the Effect of Pelvic Floor Muscle Training on Urinary Incontinence - A Literature Review
Current Women`s Health Reviews Amiodarone - A ‘Broad Spectrum’ Antiarrhythmic Drug
Cardiovascular & Hematological Disorders-Drug Targets Mineralocorticoid Receptor Antagonism and Cardiac Remodeling in Ischemic Heart Failure
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Hypertension Impairs Cerebral Blood Flow in a Mouse Model for Alzheimer’s Disease
Current Alzheimer Research Role of Renin Angiotensin System Inhibitors in Cardiovascular and Renal Protection: A Lesson from Clinical Trials
Current Pharmaceutical Design Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) The Role of Hypocarbia in the Development of Cystic Periventricular Leukomalacia
Current Pediatric Reviews Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Current Protein & Peptide Science Prognostic Implications of Genetics in Cardiovascular Disease
Current Pharmacogenomics Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Current Pharmaceutical Design Relaxin as a Cardiovascular Drug: A Promise Kept
Current Drug Safety The Vernakalant Story: How Did It Come to Approval in Europe and What is the Delay in the U.S.A?
Current Cardiology Reviews Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Sevoflurane in Intraoperative and Postoperative Cardiac Surgery Patients. Our Experience in Intensive Care Unit with Sevoflurane Sedation
Current Pharmaceutical Design Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
Current Cancer Drug Targets